Skip to content

SINOVAC BIOTECH LTD: 20-F/A filed 2013-05-23

What SINOVAC BIOTECH LTD reported in its annual report amendment (foreign private issuer) filed 2013-05-23 (fiscal FY 2012): 42 published measures, 111 facts as tagged in accession 0001104659-13-044076.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
20-F/A (annual report amendment (foreign private issuer))
Filed
2013-05-23
Fiscal period
fiscal FY 2012
Accession
0001104659-13-044076 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SINOVAC BIOTECH LTD filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-31208,763,267USD
At 2011-12-31215,908,129USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-3179,327,904USD
At 2011-12-3170,610,658USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31117,723,810USD
At 2011-12-31129,920,943USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3191,240,956USD
At 2011-12-31104,286,695USD
At 2010-12-31101,585,490USD
At 2009-12-3174,953,212USD

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-3116,156,610USD366
2011-01-01 to 2011-12-3114,989,876USD365
2010-01-01 to 2010-12-3124,817,168USD365

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-01-01 to 2012-12-3154,926,440shares366
2011-01-01 to 2011-12-3154,608,919shares365
2010-01-01 to 2010-12-3153,064,968shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-01-01 to 2012-12-3154,926,440shares366
2011-01-01 to 2011-12-3154,608,919shares365
2010-01-01 to 2010-12-3153,064,968shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-883,897USD366
2011-01-01 to 2011-12-315,066,603USD365
2010-01-01 to 2010-12-31-703,882USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-3180,083,383USD
At 2011-12-3175,627,881USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31347,226USD366
2011-01-01 to 2011-12-31206,301USD365
2010-01-01 to 2010-12-31459,901USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-21,150,773USD366
2011-01-01 to 2011-12-313,374,462USD365
2010-01-01 to 2010-12-31-13,356,464USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-31126,282,645USD
At 2011-12-31132,039,085USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-3130,154,695USD
At 2011-12-3139,530,723USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2012-12-311,149,914USD
At 2011-12-311,336,254USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-3123,440,135USD
At 2011-12-3117,834,407USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-01-01 to 2012-12-3151,267,157USD366
2011-01-01 to 2011-12-3132,340,020USD365
2010-01-01 to 2010-12-3130,039,163USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-12-3110,529,476USD
At 2011-12-318,113,428USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-3130,116,384USD366
2011-01-01 to 2011-12-3135,714,482USD365
2010-01-01 to 2010-12-3116,682,699USD365

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-3119,099,927USD366
2011-01-01 to 2011-12-3121,127,410USD365
2010-01-01 to 2010-12-3116,718,727USD365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2012-01-01 to 2012-12-3131,685,185USD366
2011-01-01 to 2011-12-3122,372,095USD365
2010-01-01 to 2010-12-3118,885,270USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-01-01 to 2012-12-3117,043,565USD366
2011-01-01 to 2011-12-319,006,550USD365
2010-01-01 to 2010-12-318,507,796USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3155,091,561shares
At 2011-12-3154,773,961shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2012-12-3111,770,927USD
At 2011-12-319,978,325USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-12-31129,435,363USD
At 2011-12-31145,297,471USD
At 2010-12-31147,756,495USD
At 2009-12-3184,466,442USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-31103,304,817USD
At 2011-12-3191,646,697USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-3121,045,902USD
At 2011-12-3116,018,816USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-12-31483,278USD
At 2011-12-31828,902USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-317,514,221USD
At 2011-12-314,119,443USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-311,072,078USD
At 2011-12-311,804,555USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-12-31445,589USD
At 2011-12-31419,114USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-19,632,575USD366
2011-01-01 to 2011-12-314,666,909USD365
2010-01-01 to 2010-12-31-13,305,885USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-18,748,678USD366
2011-01-01 to 2011-12-31-399,694USD365
2010-01-01 to 2010-12-31-12,602,003USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-13,060,039USD366
2011-01-01 to 2011-12-312,266,736USD365
2010-01-01 to 2010-12-31-5,848,706USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-14,852,641USD366
2011-01-01 to 2011-12-31-844,696USD365
2010-01-01 to 2010-12-31-8,507,344USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,259,547USD366
2011-01-01 to 2011-12-314,557,268USD365
2010-01-01 to 2010-12-313,685,480USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,487,411USD366
2011-01-01 to 2011-12-314,825,613USD365
2010-01-01 to 2010-12-314,232,103USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-866,693USD366
2011-01-01 to 2011-12-312,221,408USD365
2010-01-01 to 2010-12-311,004,607USD365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-17,204USD366
2011-01-01 to 2011-12-312,845,195USD365
2010-01-01 to 2010-12-31-1,708,489USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2012-01-01 to 2012-12-31749,500USD366
2011-01-01 to 2011-12-31455,851USD365
2010-01-01 to 2010-12-311,017,502USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-31508,160USD366
2011-01-01 to 2011-12-31748,800USD365
2010-01-01 to 2010-12-3162,255,261USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-314,285,669USD366
2011-01-01 to 2011-12-31-5,474,602USD365
2010-01-01 to 2010-12-31-1,003,642USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-12-31425,853USD366
2011-01-01 to 2011-12-311,915,078USD365
2010-01-01 to 2010-12-318,597,440USD365

Inspect the source

Entity
SINOVAC BIOTECH LTD / CIK 0001084201
Captured
2026-09-20T05:21:01.257Z
SEC response SHA-256
cdda69bdfa617478b5f42edb5b3f08feb3da6c25f952018cb739eb69454da6fa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001084201.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))